Stay updated on Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial
Sign up to get notified when there's something new on the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page.

Latest updates to the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page shows a new site revision (v3.4.2) with recent date stamps (2026-02-10, 2026-02-09, 2026-01). The funding-status notice and older 2024 items were removed as routine maintenance.SummaryDifference0.6%

- Check21 days agoChange DetectedAdded a site-wide funding-status notice at the top of the page and updated the Publications section with a new citation while removing a prior ahead-of-print reference. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedThe page now includes a glossary toggle and related topic links (Multiple Myeloma, MedlinePlus Genetics) and shows QC/version metadata (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). The older QC label (Last Update Submitted that met QC Criteria), No FEAR Act data, and Revision: v3.3.4 were removed.SummaryDifference0.3%

- Check35 days agoChange DetectedRemoved 'Multiple myeloma' and the 'MedlinePlus Genetics' related topic from the related topics section. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics to the page; no changes to study details or eligibility criteria.SummaryDifference0.1%

- Check49 days agoChange DetectedRemoved the term 'Multiple myeloma' from the page content and deleted the MedlinePlus Genetics related topic.SummaryDifference0.1%

Stay in the know with updates to Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page.